Fierce Biotech White Logo Fierce Biotech White Logo

Redesigning Commercial Model for Rare Disease: Understanding the Patient to Structure for Success

Available on-demand
60 Minutes

Rare Disease products account for half of all FDA approvals, most with fast-track designations, which means compressed launch timelines and increasingly competitive markets with smaller patient populations. The traditional commercial playbook has been upended, commercial success requires a deep understanding of the rare disease patient journey, caregiver, and HCP needs. Pharmaceutical manufacturers must be willing to examine their commercial infrastructure and build critical capabilities, to ensure product access and support that meets the patient and HCP needs. Herspiegel Consulting's commercial experts share a framework developed from 100+ pharmaceutical product launches.

Join us for this webinar to learn best practices for:

  • Commercial infrastructure
  • Developing deeper patient understanding and engagement
  • Designing more impactful HCP interactions
  • Operationalizing strategies for product access

If you are developing assets for rare disease indications, take advantage of this presentation to learn how to ensure your commercial organization is set up for success.


Swathi Rangan

Swathi Rangan

Swathi leverages her passion and expertise within the sciences to develop and lead teams to help clients craft successful solutions to complex commercial challenges. Her expertise includes leading strategy and implementation across commercial projects with a strong focus on data and insight-driven innovation; projects include patient support and experience design, digital health partnership implementation, and go-to-market strategy development. She also specializes in creating comprehensive market-shaping strategies for complex disease states and has successfully managed numerous product launches.

Vincent Piccioni

Vincent Piccioni

Vincent is Vice President, Client Success, at Herspiegel Consulting, and an accomplished life sciences professional. His background in biomedical engineering and expertise in quantitative business insights deliver data-driven strategy and operational action plans to improve patient experience and product performance. He has experience commercializing cell and gene therapies, and rare disease pharmaceutical products.

Register here to watch on-demand!

60 Minutes